{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:47:24Z","timestamp":1792234044310,"version":"4.4.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.schres.2026.10.006","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:01:34Z","timestamp":1792224094000},"page":"175-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Toxoplasma serology: Breaking the diagnostic boundary of schizoaffective disorder? Insights from a comparative peripheral immune marker analysis"],"prefix":"10.1016","volume":"298","author":[{"given":"Bruno","family":"Romeo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Jeannin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentine","family":"Lestra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Amirouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amine","family":"Benyamina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Hamdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2026.10.006_bb0005","doi-asserted-by":"crossref","DOI":"10.1007\/s00436-025-08498-w","article-title":"Association of neurobiological and immune serum biomarkers with Toxoplasma gondii infection in patients with schizophrenia","volume":"124","author":"Abramova","year":"2025","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.schres.2026.10.006_bb0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2025.03.008","article-title":"Toxoplasmosis infection and schizophrenia: elevated IgM reactivity index as a predictor of symptom worsening in chronic schizophrenia","volume":"278","author":"Alvim","year":"2025","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.10.006_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2024.107263","article-title":"Correlation between toxoplasmosis and schizophrenia in Egyptian patients and its impact on dopamine serum levels","volume":"256","author":"Ammar","year":"2024","journal-title":"Acta Trop."},{"key":"10.1016\/j.schres.2026.10.006_bb0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41537-025-00630-0","article-title":"Toxoplasma gondii associated with psychotic symptom load and cortisol in severe mental illness","volume":"11","author":"Andreou","year":"2025","journal-title":"Schizophrenia (Heidelb)"},{"key":"10.1016\/j.schres.2026.10.006_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-55887-9","article-title":"Toxoplasma gondii infection associated with inflammasome activation and neuronal injury","volume":"14","author":"Andreou","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.schres.2026.10.006_bb0030","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.4049\/jimmunol.151.3.1441","article-title":"IL-4 release by human leukemic and activated normal basophils","volume":"151","author":"Arock","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.schres.2026.10.006_bb0035","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0013-7006(05)82401-7","article-title":"Current issues on schizoaffective disorder","volume":"31","author":"Azorin","year":"2005","journal-title":"Encephale"},{"key":"10.1016\/j.schres.2026.10.006_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1319","article-title":"Global seroprevalence of toxoplasma gondii infection among patients with mental and neurological disorders: a systematic review and meta-analysis","volume":"6","author":"Bisetegn","year":"2023","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.schres.2026.10.006_bb0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.schres.2026.03.007","article-title":"Association between Toxoplasma gondii IgG seropositivity and schizophrenia: a case-control study in Colombia","volume":"292","author":"Cano","year":"2026","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.10.006_bb0050","article-title":"Complete blood count-based inflammatory ratios in people with bipolar disorder: a systematic review and meta-analysis of neutrophil-to-lymphocyte, monocyte-to-lymphocyte, and platelet-to-lymphocyte ratios","volume":"69","author":"Cavaleri","year":"2026","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2026.10.006_bb0055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jad.2007.07.009","article-title":"Does schizoaffective disorder really exist? A systematic review of the studies that compared schizoaffective disorder with schizophrenia or mood disorders","volume":"106","author":"Cheniaux","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.schres.2026.10.006_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2023.11.029","article-title":"Immune cell alterations in psychotic disorders: a comprehensive systematic review and meta-analysis","author":"Clausen","year":"2024","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2026.10.006_bb0065","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jpsychires.2022.07.013","article-title":"Association between toxoplasmosis and bipolar disorder: a systematic review and meta-analysis","volume":"153","author":"Cossu","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2026.10.006_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005643","article-title":"GLT-1-dependent disruption of CNS glutamate homeostasis and neuronal function by the protozoan parasite toxoplasma gondii","volume":"12","author":"David","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.schres.2026.10.006_bb0075","first-page":"1517","article-title":"Exploring difference and overlap between schizophrenia, schizoaffective and bipolar disorders using resting-state brain functional networks","volume":"2014","author":"Du","year":"2014","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"10.1016\/j.schres.2026.10.006_bb0080","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1001\/jamapsychiatry.2024.4941","article-title":"Differences in blood leukocyte subpopulations in schizophrenia: a systematic review and Meta-analysis","volume":"82","author":"Dudeck","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2026.10.006_bb0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eurpsy.2016.09.001","article-title":"Toxoplasma-infected subjects report an obsessive-compulsive disorder diagnosis more often and score higher in obsessive-compulsive inventory","volume":"40","author":"Flegr","year":"2017","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2026.10.006_bb0090","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.schres.2018.05.007","article-title":"Latent toxoplasma infection in real-world schizophrenia: results from the national FACE-SZ cohort","volume":"201","author":"Fond","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.10.006_bb0095","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00406-017-0847-1","article-title":"Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort","volume":"268","author":"Fond","year":"2018","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2026.10.006_bb0105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jad.2015.03.038","article-title":"Cognitive deterioration among bipolar disorder patients infected by toxoplasma gondii is correlated to interleukin 6 levels","volume":"179","author":"Hamdani","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.schres.2026.10.006_bb0100","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jad.2012.11.034","article-title":"Relationship between toxoplasma gondii infection and bipolar disorder in a French sample","volume":"148","author":"Hamdani","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.schres.2026.10.006_bb0110","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3109\/15622975.2011.573809","article-title":"Latent toxoplasmosis reduces gray matter density in schizophrenia but not in controls: voxel-based-morphometry (VBM) study","volume":"13","author":"Horacek","year":"2012","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2026.10.006_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.278","article-title":"Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization","volume":"7","author":"Howes","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.schres.2026.10.006_bb0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jpsychires.2026.02.041","article-title":"Could peripheral immunological markers discriminate schizophrenia and schizoaffective disorders from bipolar disorder?","volume":"197","author":"Jeannin","year":"2026","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2026.10.006_bb0125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-immunol-031210-101257","article-title":"Nonredundant roles of basophils in immunity","volume":"29","author":"Karasuyama","year":"2011","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.schres.2026.10.006_bb1105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.10.006_bb0130","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","article-title":"Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment","volume":"2","author":"Khandaker","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2026.10.006_bb0135","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/YCO.0b013e3281a305ab","article-title":"Schizoaffective disorder merges schizophrenia and bipolar disorders as one disease--there is no schizoaffective disorder","volume":"20","author":"Lake","year":"2007","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.schres.2026.10.006_bb0140","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.schres.2022.06.026","article-title":"Could CRP be a differential biomarker of illness stages in schizophrenia? A systematic review and meta-analysis","volume":"246","author":"Lestra","year":"2022","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.10.006_bb0145","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/schbul\/sbab004","article-title":"Long-term real-world effectiveness of pharmacotherapies for schizoaffective disorder","volume":"47","author":"Lintunen","year":"2021","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.10.006_bb0150","doi-asserted-by":"crossref","first-page":"15092","DOI":"10.1038\/s41598-022-16420-y","article-title":"Association between toxoplasma gondii infection and psychiatric disorders: a cross-sectional study in China","volume":"12","author":"Liu","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.schres.2026.10.006_bb0155","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1017\/S0033291720002020","article-title":"A meta-analysis comparing cognitive function across the mood\/psychosis diagnostic spectrum","volume":"52","author":"Lynham","year":"2022","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2026.10.006_bb0160","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3892\/br.2024.1774","article-title":"A comprehensive assessment of toxoplasmosis and its dormant impact on psychotic disorders (review)","volume":"20","author":"Mares","year":"2024","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.schres.2026.10.006_bb0165","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbi.2014.08.001","article-title":"Toxoplasma gondii and anxiety disorders in a community-based sample","volume":"43","author":"Markovitz","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.schres.2026.10.006_bb0170","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.euroneuro.2011.03.001","article-title":"What we know and what we don't know about the treatment of schizoaffective disorder","volume":"21","author":"Murru","year":"2011","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2026.10.006_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583824","article-title":"Basophils and eosinophils in nematode infections","volume":"11","author":"Obata-Ninomiya","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.schres.2026.10.006_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10060369","article-title":"Pathophysiological mechanisms of cognitive impairment and neurodegeneration by toxoplasma gondii infection","volume":"10","author":"Ortiz-Guerrero","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.schres.2026.10.006_bb0185","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/bdi.12057","article-title":"Characteristics of patients diagnosed with schizoaffective disorder compared with schizophrenia and bipolar disorder","volume":"15","author":"Pagel","year":"2013","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.schres.2026.10.006_bb0190","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.014183","article-title":"Chronic murine toxoplasmosis is defined by subtle changes in the neuronal connectivity","author":"Parlog","year":"2014","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.schres.2026.10.006_bb0195","first-page":"42","article-title":"The modern concept of schizoaffective disorder: a narrative review","volume":"5","author":"Pavlichenko","year":"2024","journal-title":"Consort. Psychiatr."},{"key":"10.1016\/j.schres.2026.10.006_bb0200","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.64.1.19","article-title":"Lifetime prevalence of psychotic and bipolar I disorders in a general population","volume":"64","author":"Per\u00e4l\u00e4","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2026.10.006_bb0205","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1073\/pnas.81.3.908","article-title":"Interferon gamma blocks the growth of toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan","volume":"81","author":"Pfefferkorn","year":"1984","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.schres.2026.10.006_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12111333","article-title":"The modulated role of toxoplasma gondii on eosinophils in psychiatric disorders after cannabis cessation","volume":"12","author":"Romeo","year":"2023","journal-title":"Pathogens"},{"issue":"3","key":"10.1016\/j.schres.2026.10.006_bb0215","first-page":"142","article-title":"Basophils: new players in the cytokine network","volume":"21","author":"Schneider","year":"2010","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.schres.2026.10.006_bb0220","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/schbul\/sbm030","article-title":"Toxoplasma gondii and schizophrenia: linkage through astrocyte-derived kynurenic acid?","volume":"33","author":"Schwarcz","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.10.006_bb0225","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejphar.2015.04.049","article-title":"Basophils in inflammation","volume":"778","author":"Schwartz","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2026.10.006_bb0230","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-019-0636-x","article-title":"The association between antibodies to neurotropic pathogens and bipolar disorder: a study in the Dutch Bipolar (DB) cohort and meta-analysis","volume":"9","author":"Snijders","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.schres.2026.10.006_bb0235","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/acps.12423","article-title":"Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis","volume":"132","author":"Sutterland","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2026.10.006_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens6020019","article-title":"Neurophysiological changes induced by chronic Toxoplasma gondii infection","volume":"6","author":"Tedford","year":"2017","journal-title":"Pathogens"},{"key":"10.1016\/j.schres.2026.10.006_bb0245","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neubiorev.2018.11.012","article-title":"Toxoplasmosis: a pathway to neuropsychiatric disorders","volume":"96","author":"Tyebji","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2026.10.006_bb0255","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/schbul\/sby082","article-title":"Toxoplasma gondii: biological parameters of the connection to schizophrenia","volume":"44","author":"Xiao","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.10.006_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106313","article-title":"Inflammation manipulation and a complement-centered reboot of the toxoplasma gondii model of schizophrenia","volume":"177","author":"Xiao","year":"2025","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2026.10.006_bb0260","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.schres.2021.02.007","article-title":"Mapping relationships among schizophrenia, bipolar and schizoaffective disorders: a deep classification and clustering framework using fMRI time series","volume":"245","author":"Yan","year":"2022","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.10.006_bb0265","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jpsychires.2024.05.025","article-title":"Toxoplasma gondii infection positively associated with schizophrenia: Evidences from UK Biobank cohort and case-controlled studies","volume":"175","author":"Yang","year":"2024","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2026.10.006_bb0270","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/intimm\/dxy002","article-title":"Host responses to intestinal nematodes","volume":"30","author":"Yasuda","year":"2018","journal-title":"Int. Immunol."},{"key":"10.1016\/j.schres.2026.10.006_bb0275","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cyto.2015.05.010","article-title":"T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production","volume":"75","author":"Zhu","year":"2015","journal-title":"Cytokine"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426003579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426003579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:18:13Z","timestamp":1792232293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996426003579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":56,"alternative-id":["S0920996426003579"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.10.006","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxoplasma serology: Breaking the diagnostic boundary of schizoaffective disorder? Insights from a comparative peripheral immune marker analysis","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}